Skip to main content
Skip to footer
We're taking you to another TCS website now.

SCOPE Europe is a hybrid event serving clinical innovation leaders, clinical operations executives, digital leaders, functional heads, category managers, and those responsible for the planning and management of clinical trials. TCS ADDTM was a ‘Premier Sponsor’ of the reputed event, that aims to bring together industry stalwarts from across the globe to share insights into the new era of decentralized, analytics-driven, and patient-centric trials.

TCS ADD™ platforms had multiple playspots across the event that helped drive more than 100 booth footfalls. Interesting discussions and proof of concept notes with pharma around risk based monitoring, data management and clinical supply management rounded off our fruitful presence at the conference.

Key Stats

  • 50+ pharma logos at the event
  • 250+ in-person attendees
  • 100+ booth footfalls
  • 10,000+ digital engagements


Drop by our booth #14 for a demo and experience the novel, intelligent and intuitive solutions from TCS ADDTM





Session 1 (April 20, 10:15 CET)

Medication data – A fundamental cornerstone for successful trials

With the introduction of decentralized trial models, medication adherence has become extremely convoluted. The need for introducing automation and smart medication technologies has never been more acute. In this session, Dr.Ingram will share easy and practical approaches to automate supply activities and provide personalized patient support across traditional, decentralized, and hybrid models.


  • Dr. Paul Ingram, Industry Leader, Supply Management, TCS ADD™ Connected Clinical Trials, TCS 



Session 2 (April 20, 14:50 CET)

Leveraging Feasibility Data and Stimulating Participation Rates to Improve Site Selection, Study Design and Outcome Prediction

Performing early development planning, feasibility assessment, protocol development, and site selection are crucial stages of clinical trials affecting both the time and budget involved in the process. Thus, in this session Dr. Niraj will talk about innovative data analytics capabilities, new protocol development and feasibility assessment processes, and novel approaches to stakeholder communication and collaboration.


  • Dr. Niraj Vyas, AVP and Head, TCS ADD™  Analytics and Insights




Session 3 (April 20, 16:25 CET)

Advanced Analytics and Artificial Intelligence in Clinical Trials

This session focuses on AI application in clinical data management, advanced analytics and AI capabilities driving quality compliance. Dr. Niraj will be picking up use cases of AI/ML and will describe implementation of an idea quickly.


  • Dr. Niraj Vyas, AVP and Head, TCS ADD™ Analytics and Insights, TCS



Session 4 (April 21, 15:00 CET)

Redefining dynamic monitoring with an AI-based predictive analytics approach – A real-life use case

The lack of clinical operations oversight and disjointed communication at site and study levels have proved to be detrimental for the life sciences industry. The need to leverage a data science-led approach is a must to address these complexities. In this session, speakers Dr. Vyas and Lauwers will touch upon the novel approaches and enablers in dynamic monitoring and support them with a real-life use case. 


  • Saurabh Das, Head, Research and Innovation, TCS ADD™ Analytics and Insights, TCS
  • Kris Lauwers, Data Science Manager, Janssen R&D




Session 5 (April 21, 16:00 CET)

The Role of Patients, Data, and Patient-Facing Technologies in Clinical Trial Design: Lessons from COVID-19 Pandemic

This session will focus on providing measures to be taken for offsetting challenges brought about by COVID-19, including clinical trial design from a site perspective, patient-centric digital solutions, creating an inclusive/equitable environment, collaborating within regulatory affairs.


  • Dr. Hilde Vanaken, Head, Industry Leaders, Life Sciences and Healthcare, TCS


  1. For more info on TCS ADD Analytics and Insights, visit
  2. For more info on TCS ADD Supply Management and TCS ADD Patient and Site Engagement, visit
  3. Register for SCOPE Europe 2022
  4. Listen to pharma leaders as they delve deep into the dynamic monitoring space
  5. Learn about the next-gen clinical trials via digital platforms, visit